Related Experiment Video
Updated: Aug 11, 2026

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
Published on: August 20, 2016
Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium
R A Eiferman1, J P Snyder, R E Nordquist
1Research Service, Veterans Administration Medical Center, Louisville, Kentucky, USA. reiferman@cs.com
Abstract:
In 4 corneal transplantation patients treated preoperatively with ciprofloxacin ophthalmic drops, microprecipitates associated with damaged corneal epithelium were noted in 2 patients. Another patient developed a large macroprecipitate in a corneal ulcer. All specimens were examined by electron microscopy and high-pressure liquid chromatography. The crystalline precipitates were pure ciprofloxacin. The macroprecipitate demonstrated a large zone of inhibition on agar plates seeded with a susceptible organism at 24 and 48 hours. It was bioactive and bioavailable in vitro.
Insights
Ciprofloxacin eye drops can form precipitates in the cornea after surgery. These precipitates, identified as pure ciprofloxacin, showed antibacterial activity in lab tests.
Area of Science:
- Ophthalmology
- Pharmacology
- Materials Science
Background:
- Corneal transplantation is a surgical procedure to restore vision.
- Ciprofloxacin ophthalmic drops are commonly used to prevent infection.
- Epithelial damage can occur during or after corneal surgery.
Observation:
- Microprecipitates were observed in the corneas of 2 out of 4 patients receiving preoperative ciprofloxacin.
- A large macroprecipitate formed in a corneal ulcer in another patient.
- These precipitates were analyzed using electron microscopy and high-pressure liquid chromatography.
Findings:
- The crystalline precipitates were identified as pure ciprofloxacin.
- The macroprecipitate exhibited significant antibacterial activity in vitro, demonstrating a large zone of inhibition.
- The precipitates were confirmed to be bioactive and bioavailable in laboratory settings.
Implications:
- Ciprofloxacin precipitates may form in damaged corneal tissue.
- The precipitates retain antibacterial properties, suggesting potential therapeutic roles.
- Further research is needed to understand the clinical significance and management of these precipitates in ophthalmic surgery.

